Pain Relief With Integrative Medicine (PRIMe)?: Feasibility of Acupuncture for Long COVID

Part of paid clinical trials in Seattle, Washington.

Sponsor
University of Washington
Study ID
NCT06476496
Status
Completed

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Accepted

Interventions

  • Acupuncture — PROCEDURE
    A licensed acupuncturist will insert sterile disposable acupuncture needles in the selected body and ear acupoints aiming to alleviate long COVID related pain symptoms. Needles will be removed after 20 minutes of retention. After all the needles are removed, the acupuncturist will insert Pyonex press tack needles (0.3mm) in the participants' left ears and suggest the participants retain them in their ears for up to 5 days.

Study Details

The goal of this preliminary study is to test methods and procedures to be used in a fully-powered trial to evaluate acupuncture treatment effectiveness. Specifically, we will test the feasibility of conducting a 2-arm randomized clinical trial for evaluating the effectiveness of acupuncture for pain in patients with long COVID. Researchers will compare pain intensity and impact on general activities over 5 months in those who receive acupuncture treatment compared to patients who are receiving usual long COVID care. Participants will complete 4 online surveys at weeks 0, 4, 8, and 20. These surveys include validated mental and physical health questionnaires. Participants who are randomly selected to receive the intervention will receive 8 acupuncture treatment sessions.

Key Dates

Start date
Jun 21, 2024
Status verified
May 2026
Primary completion
Mar 30, 2025
Completion
Jun 23, 2025

Study Design

Enrollment
93 participants (actual)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Experimental: Acupuncture
    Participants will receive 8 sessions of acupuncture treatment
  • No Intervention: Usual Care
    Participants will continue to receive any current or recommended treatments from their doctors for their long COVID symptoms.

Primary Outcome Measure

Pain, Enjoyment and General Activity (PEG) [ Time Frame: Baseline (Week 0), Mid-Point (Week 4), Post-Intervention (Week 8), and Final Follow-Up (Week 20) ]

Locations (1)

FacilityCityStateZIPSite coordinators
UW Medicine Primary Care at NorthgateSeattleWashington98125-

Find similar trials in Seattle, WA

By condition
COVID-19 / long COVID
By specialty
Infectious disease
By research site
UW Medicine Primary Care at Northgate· Seattle, WA

Related Studies